Haemonetics (HAE) EBT (2009 - 2026)

Haemonetics has reported EBT for 18 years, with the latest figure at $47.6 million in Q2 2026.

• On a quarterly basis, EBT rose 5.32% year-over-year to $47.6 million in Q2 2026; TTM through Jun 2026 was $130.4 million, a 38.04% decrease from a year earlier, with the FY2026 full-year figure at $128.0 million, down 39.63% from the prior year.
• EBT was $47.6 million for Q2 2026 at Haemonetics, up from -$28.4 million in the prior quarter.
• The five-year high for EBT was $70.7 million in Q1 2025, with the low at -$28.4 million in Q1 2026.
• Average EBT over 5 years is $38.3 million, with a median of $44.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: EBT jumped 947.54% in 2022, then slumped 140.15% in 2026.
• Over 5 years, EBT stood at $42.2 million in 2022, then increased by 4.27% to $44.0 million in 2023, then advanced by 13.37% to $49.9 million in 2024, then gained by 20.15% to $60.0 million in 2025, then slipped by 20.68% to $47.6 million in 2026.
• The last three EBT figures came in at $47.6 million (Q2 2026), -$28.4 million (Q1 2026), and $60.0 million (Q4 2025), per Business Quant data.